MAXCYTE, INC. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
MaxCyte, Inc. executed a severance agreement with CFO Parmeet Ahuja effective August 11, 2026. The agreement provides for cash severance equal to base salary plus target bonus (paid monthly over 9–12 months depending on trigger type), 100% acceleration of unvested equity awards, and COBRA premium coverage upon termination without Cause or following a Change of Control. No specific salary or bonus dollar amounts are stated in the filing.
Why this rating
Severance agreements with named executives are routine filings. CFO is key but not CEO. No dollar amounts disclosed; equity acceleration is standard. No immediate business impact.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.